The Colistimethate Sodium, cataloged under National Stock Number 6505-01-631-0883, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-631-0883 |
| Primary Part Number | NDC63323-0393-06 |
| Item Name | Colistimethate Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL, SINGLE DOSE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0393-06 PRIMARY | Fresenius Kabi, Llc (USA) |
| NDC42023-0107-01 PRIMARY | Par Pharmaceutical, Inc. Dba Par Pharmaceutical (USA) |
| NDC70594-0023-01 PRIMARY | Xellia Pharmaceuticals Usa Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM141379 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1176681 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-631-0883 is a Colistimethate Sodium, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-631-0883 has 3 manufacturer part numbers on file: NDC63323-0393-06 (Fresenius Kabi, Llc), NDC42023-0107-01 (Par Pharmaceutical, Inc. Dba Par Pharmaceutical), NDC70594-0023-01 (Xellia Pharmaceuticals Usa Llc).
Key specifications for NDC63323-0393-06: Administration: INTRAMUSCULAR AND INTRAVENOUS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE; Primary Container Type: VIAL, SINGLE DOSE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.